CytoReason has today announced a collaboration with Pfizer â as the machine learning company eyes future partnerships with industry leaders to up the accuracy of its models and affect decision-making throughout the drug development pipeline, says CEO.
Original Article: Pfizer taps CytoReason’s machine learning platform for drug discovery